Hepatic response to chronic hypoxia in experimental rat model through HIF-1 alpha, activator protein-1 and NF-kappa B

Histology and Histopathology

Volumn 28, Issue 4, 2013, Pages 463-471

  Lau, Thomas Y H ^a   Xiao, Jia ^b,f   Liong, Emily C ^b   Liao, Linchuan ^c   Leung, Tung Ming ^b,e   Nanji, Amin A ^d   Fung, Man Lung ^b   Tipoe, George L ^b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SICHUAN UNIVERSITY   (China)

^d DALHOUSIE UNIVERSITY   (Canada)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Hypoxia; Nitric oxide; Nuclear transcription factors; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT; PROSTAGLANDIN F2 ALPHA; TRANSCRIPTION FACTOR AP 1; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; ANOXIA; ARTICLE; BLOOD; CHRONIC DISEASE; DISEASE MODEL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; ANOXIA; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHRONIC DISEASE; DINOPROST; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIN-1; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84876434068     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baze M.M., Schlauch K. and Hayes J.P. (2010). Gene expression of the liver in response to chronic hypoxia. Physiol. Genomics 41, 275-288
2. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L. and Sharp F.R. (1999). Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11, 4159-4170.
3. Bianciardi P., Fantacci M., Caretti A., Ronchi R., Milano G., Morel S., von Segesser L., Corno A. and Samaja M. (2006). Chronic in vivo hypoxia in various organs: hypoxia-inducible factor-1alpha and apoptosis. Biochem. Biophys. Res. Commun. 342, 875-880.
4. Bozova S. and Elpek G.O. (2007). Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis. APMIS 115, 795-801.
5. Chen J.H., Tipoe G.L., Liong E.C., So H.S., Leung K.M., Tom W.M., Fung P.C. and Nanji A.A. (2004). Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am. J. Clin. Nutr. 80, 742-751.
6. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., Housset C. and Rosmorduc O. (2002). Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35, 1010-1021.
7. Cummins E.P. and Taylor C.T. (2005). Hypoxia-responsive transcription factors. Pflugers Arch. 450, 363-371.
8. Ferrara N. (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543.
9. Heidbreder M., Frohlich F., Johren O., Dendorfer A., Qadri F. and Dominiak P. (2003). Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J. 17, 1541-1543.
10. Hoffmann A., Gloe T. and Pohl U. (2001). Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J. Cell Physiol. 188, 33-44.
11. Hu J., Discher D.J., Bishopric N.H. and Webster K.A. (1998). Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245, 894-899.
12. Huang G.W., Yang L.Y. and Lu W.Q. (2005). Expression of hypoxiainducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J. Gastroenterol. 11, 1705-1708.
13. Jeffery T.K. and Wanstall J.C. (2001). Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther. 92, 1-20.
14. Jeong W.I., Do S.H., Yun H.S., Song B.J., Kim S.J., Kwak W.J., Yoo S.E., Park H.Y. and Jeong K.S. (2004). Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver. Liver Int. 24, 658-668.
15. Jozkowicz A., Dulak J., Nigisch A., Funovics P., Weigel G., Polterauer P., Huk I. and Malinski T. (2004). Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms. Growth Factors 22, 19-28.
16. Koong A.C., Chen E.Y. and Giaccia A.J. (1994). Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 54, 1425-1430.
17. Kumar S., Sun X., Wedgwood S. and Black S.M. (2008). Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. Am. J. Physiol. Lung Cell Mol, Physiol, 295, L370-377.
18. Lam S.Y., Tipoe G.L., Liong E.C. and Fung M.L. (2008a). Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body. Histochem. Cell Biol. 130, 549-559.
19. Lam S.Y., Tipoe G.L., Liong E.C. and Fung M.L. (2008b). Differential expressions and roles of hypoxia-inducible factor-1alpha, -2alpha and -3alpha in the rat carotid body during chronic and intermittent hypoxia. Histol. Histopathol. 23, 271-280.
20. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W. and Thistlethwaite P.A. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342, 626-633.
21. Mansoor A.M., Honda M., Saida K., Ishinaga Y., Kuramochi T., Maeda A., Takabatake T. and Mitsui Y. (1995). Endothelin induced collagen remodeling in experimental pulmonary hypertension. Biochem. Biophys. Res. Commun. 215, 981-986.
22. Nanji A.A., Griniuviene B., Sadrzadeh S.M., Levitsky S. and McCully J.D. (1995). Effect of type of dietary fat and ethanol on antioxidant enzyme mRNA induction in rat liver. J. Lipid Res. 36, 736-744.
23. Nanji A.A., Zakim D., Rahemtulla A., Daly T., Miao L., Zhao S., Khwaja S., Tahan S.R. and Dannenberg A.J. (1997). Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26, 1538-1545.
24. Nanji A.A., Jokelainen K., Rahemtulla A., Miao L., Fogt F., Matsumoto H., Tahan S.R. and Su G.L. (1999). Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30, 934-943.
25. Oshita M., Takei Y., Kawano S., Yoshihara H., Hijioka T., Fukui H., Goto M., Masuda E., Nishimura Y. and Fusamoto H. (1993). Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J. Clin. Invest. 91, 1337-1342.
26. Peacock A.J., Dawes K.E., Shock A., Gray A.J., Reeves J.T. and Laurent G.J. (1992). Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am. J. Respir. Cell. Mol. Biol. 7, 492-499.
27. Sato A., Nakajima T. and Koyama Y. (1983). Interaction between ethanol and carbohydrate on the metabolism in rat liver of aromatic and chlorinated hydrocarbons. Toxicol. Appl. Pharmacol. 68, 242-249.
28. Semenza G.L. (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474-1480.
29. Semenza G.L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
30. Tipoe G.L. and Fung M.L. (2003). Expression of HIF-1alpha, VEGF and VEGF receptors in the carotid body of chronically hypoxic rat. Respir. Physiol. Neurobiol. 138, 143-154.
31. Tipoe G.L., Leung T.M., Liong E., So H., Leung K.M., Lau T.Y., Tom W.M., Fung M.L., Fan S.T. and Nanji A.A. (2006). Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury. Histol. Histopathol. 21, 1157-1165.
32. Wei W., Jin H., Chen Z.W., Zioncheck T.F., Yim A.P. and He G.W. (2004). Vascular endothelial growth factor-induced nitric oxide- and PGI2-dependent relaxation in human internal mammary arteries: a comparative study with KDR and Flt-1 selective mutants. J. Cardiovasc. Pharmacol. 44, 615-621.
33. Wenger R.H. (2002). Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16, 1151-1162.
34. Yu A.Y., Shimoda L.A., Iyer N.V., Huso D.L., Sun X., McWilliams R., Beaty T., Sham J.S., Wiener C.M., Sylvester J.T. and Semenza G.L. (1999). Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J. Clin. Invest. 103, 691-696.
35. Zagzag D., Zhong H., Scalzitti J.M., Laughner E., Simons J.W. and Semenza G.L. (2000). Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 2606-2618.
36. Zhang J.X., Pegoli W. Jr and Clemens M.G. (1994). Endothelin-1 induces direct constriction of hepatic sinusoids. Am. J. Physiol. 266, G624-632.
37. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L. and Simons J.W. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835.